← Back to Search

Tele-Navigation for Lung Cancer Screening

N/A
Waitlist Available
Led By Mayuko Ito Fukunaga, MD
Research Sponsored by University of Massachusetts, Worcester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
English speaker
Has undergone LCS at UMMH
Must not have
Has previous diagnosis of lung cancer
Has active cancer diagnosis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 180 days
Awards & highlights
No Placebo-Only Group

Summary

This trial seeks to improve follow-up of Lung Cancer Screening (LCS) through Tele-Navigation, to ultimately reduce mortality & optimize cost-effectiveness.

Who is the study for?
This trial is for English-speaking individuals who are eligible for and overdue a low-dose CT scan (LDCT) as part of lung cancer screening follow-up. Participants must have had their initial screening at UMMH and possess the technology to complete study activities, such as video calls. Those with a previous or active cancer diagnosis, nursing home residents, or pregnant individuals cannot join.
What is being tested?
The Tele-Navi LCS intervention uses telehealth to improve adherence to follow-up lung cancer screenings. The study will create this program with patient input and test its feasibility in primary care by tracking if participants complete it and their subsequent LDCT within 180 days.
What are the potential side effects?
Since Tele-Navi LCS is a non-medical intervention involving telehealth navigation support, there are no direct medical side effects associated with drugs or procedures. However, participants may experience issues related to the use of technology.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I speak English.
Select...
I have had a lung cancer screening at UMMH.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have been diagnosed with lung cancer before.
Select...
I currently have an active cancer diagnosis.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~180 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 180 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Completion of Tele-Navi LCS
Secondary study objectives
Completion of Follow-up LCS

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Tele-Navi LCSExperimental Treatment1 Intervention
Tele-Navi of LCS includes: telehealth coaching from a Tele-Navigator for patients undergoing LCS

Find a Location

Who is running the clinical trial?

Meyers Primary Care InstituteUNKNOWN
University of Massachusetts, WorcesterLead Sponsor
361 Previous Clinical Trials
992,919 Total Patients Enrolled
Wake Forest University Health SciencesOTHER
1,392 Previous Clinical Trials
2,451,884 Total Patients Enrolled

Media Library

Tele-Navi LCS Clinical Trial Eligibility Overview. Trial Name: NCT05021133 — N/A
Lung Cancer Research Study Groups: Tele-Navi LCS
Lung Cancer Clinical Trial 2023: Tele-Navi LCS Highlights & Side Effects. Trial Name: NCT05021133 — N/A
Tele-Navi LCS 2023 Treatment Timeline for Medical Study. Trial Name: NCT05021133 — N/A
~9 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top